Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
2,547,036
-
Share change
-
+2,004,943
-
Total reported value
-
$55,940,000
-
Price per share
-
$23.01
-
Number of holders
-
6
-
Value change
-
+$44,883,639
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Silence Therapeutics plc - ADS (SLN) as of Q1 2021
As of 31 Mar 2021,
Silence Therapeutics plc - ADS (SLN) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,547,036 shares.
The largest 6 holders included
Lombard Odier Asset Management (USA) Corp, BVF INC/IL, ADAGE CAPITAL PARTNERS GP, L.L.C., Consonance Capital Management LP, MORGAN STANLEY, and SG Americas Securities, LLC.
This page lists
6
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.